AnalystsDaniel MarkowitzDaniel Markowitz's Stock Forecasts
AnalystsDaniel Markowitz
Analyst Ranking
Top 31%
#1622 out of 5312 analysts
Average Return
+3.64%
Win Rate
65%20 out of 31
Risk vs Reward
Poor
Good
Daniel Markowitz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Natera IncNTRA | +89.79% | $138.00 | $261.91 | 2025-07-28 - 2026-06-26 | Buy |
Guardant Health IncGH | +60.58% | $63.44 | $101.87 | 2025-10-07 - 2026-01-05 | Buy |
West Pharmaceutical Services IncWST | +51.92% | $230.95 | $350.85 | 2026-02-03 - 2026-06-26 | Buy |
Natera IncNTRA | +34.84% | $194.24 | $261.91 | 2026-05-08 - 2026-06-26 | Buy |
West Pharmaceutical Services IncWST | +33.14% | $263.51 | $350.85 | 2025-07-25 - 2026-06-26 | Buy |
Daniel Markowitz Analyst Color
Get additional color on Daniel Markowitz's coverage of popular stocks
Daniel Markowitz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Inspire Medical Systems IncINSP | 5 | Hold | $40.00 | -12.51% | Downgrades | 6 days ago |
Natera IncNTRA | 4 | Buy | $270.00 | +3.09% | Maintains | 2 months ago |
Guardant Health IncGH | 6 | Hold | $95.00 | -36.34% | Maintains | 2 months ago |
Bio Techne CorpTECH | 6 | Hold | $50.00 | -29.58% | Maintains | 2 months ago |
Insulet CorpPODD | 3 | Buy | $200.00 | +26.38% | Maintains | 2 months ago |
Rambus IncRMBS | 4 | Buy | $172.00 | +49.92% | Maintains | 2 months ago |
Repligen CorpRGEN | 6 | Buy | $140.00 | -4.77% | Maintains | 3 months ago |
Transmedics Group IncTMDX | 3 | Buy | $118.00 | +72.41% | Maintains | 3 months ago |
Minimed Group IncMMED | 1 | Buy | $20.00 | +40.45% | Initiates Coverage On | 3 months ago |
West Pharmaceutical Services IncWST | 4 | Buy | $320.00 | -8.79% | Maintains | 5 months ago |
Dexcom IncDXCM | 1 | Hold | $68.00 | -3.05% | Initiates Coverage On | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.